Frazier Life Sciences Management, L.P. - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 190 filers reported holding PROTHENA CORP PLC in Q3 2023. The put-call ratio across all filers is 1.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q3 2023$6,171,175
-29.3%
127,9000.0%0.41%
-21.5%
Q2 2023$8,733,012
+40.9%
127,9000.0%0.52%
+16.3%
Q1 2023$6,199,313
-19.6%
127,9000.0%0.45%
-6.3%
Q4 2022$7,705,975127,9000.48%
Other shareholders
PROTHENA CORP PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,304,751$360,254,00016.93%
Palo Alto Investors LP 788,618$27,570,0002.08%
Redmile Group, LLC 487,406$17,040,0001.63%
TURNER INVESTMENTS LLC 78,870$2,757,0000.86%
Rock Springs Capital Management LP 308,000$10,768,0000.80%
SECTORAL ASSET MANAGEMENT INC 174,746$6,109,0000.63%
BB BIOTECH AG 350,000$12,236,0000.48%
MARINER INVESTMENT GROUP LLC 33,104$1,157,0000.39%
PINNACLE ASSOCIATES LTD 436,417$15,257,0000.33%
OAK RIDGE INVESTMENTS LLC 364,250$12,734,0000.33%
View complete list of PROTHENA CORP PLC shareholders